Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (3886)	5/4/1998 3:49:00 PM
From: drsvelte	Read Replies (1) \| Respond to of 7041

Linda: I am still short. IMO, the poster business is just a sideshow -- the efficacy of Vasomax clearly has not been demonstrated. My fundamental view, however, is it will be years before Vasomax sees market daylight (if it does it all.) They will be "too little, too late." Right now, the market does not share my view. But I think this is mainly a halo effect from Viagra superhype. Once this cools, the stock will slide. Maybe not to zero, as some shorts have proclaimed, but probably into the lower teens. This is my opinion, and to coin a phrase, I'm stickin' with it!